Yarrow Bioscience (YARW) Share-based Compensation (2016 - 2026)

Yarrow Bioscience (YARW) has reported Share-based Compensation for 11 consecutive years, with $436000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation fell 17.58% year-over-year to $436000.0; the trailing twelve-month figure through Jun 2026 stood at $2.2 million (down 19.19% YoY), and the FY2025 full-year result was $2.3 million, down 30.12% from the prior year.
• Share-based Compensation declined to $436000.0 in Q2 2026 per YARW's latest filing, from $474000.0 in the prior quarter.
• Across five years, Share-based Compensation topped out at $1.2 million in Q3 2022 and bottomed at $436000.0 in Q2 2026.
• Historically, Share-based Compensation has averaged $819187.5 across 5 years, with a median of $859500.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Share-based Compensation slumped 63.43% in 2022, then increased 15.07% in 2024.
• Over 5 years, Share-based Compensation stood at $1.1 million in 2022, then tumbled by 33.46% to $710000.0 in 2023, then decreased by 1.55% to $699000.0 in 2024, then decreased by 24.32% to $529000.0 in 2025, then decreased by 17.58% to $436000.0 in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $436000.0, $474000.0, and $529000.0 for Q2 2026, Q1 2026, and Q2 2025 respectively.